Exelon’s utilities subsidiary ComEd has opened applications for its annual Power for Good Grant Programs, allocating a total of $515,000 to local municipalities and nonprofits across northern Illinois. The funding is divided among three initiatives—Green Region, administered by Openlands, which supports environmental sustainability projects; Powering Safe, which backs public safety and clean transportation efforts; and an arts access program designed to broaden cultural participation. Grants range from $10,000 to $100,000 per award, with the application window closing in late March and recipients to be announced in early June.

Commonwealth Equity Services LLC sold 36,065 shares of Exelon during the third quarter, reducing its holding by 10.4% to 309,579 shares valued at approximately $13.9 million. This follows a broader pattern of portfolio adjustments by major investors: Hager Investment Management Services doubled its position to 670 shares, Albion Financial Group increased its stake by 54.7% to 928 shares, and several smaller advisers established new positions ranging from 670 to 928 shares each. Overall, institutional ownership stands at 80.9%, underscoring the influence of large shareholders on the company’s stock movement.

In its most recent quarter, Exelon reported adjusted earnings of $0.86 per share, beating consensus forecasts by $0.17, on revenues of $6.71 billion versus analyst projections of $6.40 billion. Net margin expanded to 11.6% and return on equity reached 10.3%. The company reiterated its full-year earnings outlook, narrowing the EPS range to $2.64–$2.74 from prior guidance of $2.60–$2.75, reflecting confidence in stable wholesale power prices and regulated utility performance. Free cash flow improved by 8% year-over-year, driven by tighter working capital management and strong nuclear generation availability.

Exelon declared a quarterly dividend of $0.40 per share, payable in mid-December to shareholders of record as of November 10, translating into a 3.7% annualized yield and a payout ratio of 57.4%. On the research front, Barclays upgraded its rating to overweight with a target increase from $48 to $52, while Wells Fargo assigned a strong-buy rating. Conversely, one major broker trimmed its price objective from $50 to $47 and maintained a neutral stance. The consensus among twelve analysts remains a Hold, with a blended target price near $49.85, indicating limited near-term upside according to MarketBeat data.